β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy

Care.diabetesjournals.org: July 2012. OBJECTIVE To assess β-cell function preservation after 3.5 years of intensive therapy with insulin plus metformin (INS group) versus triple oral therapy (TOT group) with metformin, glyburide, and pioglitazone. RESEARCH DESIGN AND METHODS This was a randomized trial of 58 patients with treatment-naïve newly diagnosed type 2 diabetes. All patients were treated with insulin and […]

Standard aspirin dose may not protect diabetics against blood clots

News-medical.net: Published on June 25, 2012 at 11:25 AM Many patients with type 2 diabetes may be aspirin resistant. That means the standard aspirin dose may not protect them against blood clots that cause heart attacks andstrokes among diabetics, a new clinical study finds. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston. “This result adds to […]

Overseas drug trials fuel approvals, sales

Japantimes.co.jp: By MAKIKO KITAMURA, Bloomberg Tadasuke Takahashi, a hair stylist in London, supplements his income by participating in medical trials that offer him about ¥80,000, “bento” meals and Japanese manga during a six-night stay in clinics. During the tests, Takahashi, 33, takes experimental drugs so researchers can determine if his reaction is any different to that of […]

Patients driving direction of new drug research

Articles.boston.com. June 20, 2012|Erin Ailworth, Globe Staff Scott Martin’s son was still a newborn when nurses began to suspect the baby had hemophilia. The diagnosis sent Martin and his wife into a tailspin for about six months – then they began searching for treatment. Three years later, frustrated by the lack of options, Martin, a Texas energy […]

Informed consent: A broken contract

NATURE | NEWS FEATURE:  June  20, 2012. Late in May, the direct-to-consumer gene-testing company 23andMe proudly announced the impending award of its first patent. The firm’s research on Parkinson’s disease, which used data from several thousand customers, had led to a patent on gene sequences that contribute to risk for the disease and might be used to […]

Match.coms of clinical trials make it easier to connect patients, researchers

Medcitynews.com: 6/19/2012 Eighty percent of clinical trials are delayed at least one month because of unfulfilled enrollment, according to Cutting Edge Information. That means additional time and additional costs for trial sponsors. Some have gotten creative in finding ways to let physicians know about clinical trials that might benefit their patients — through an app, for example, or with trial alerts […]

Drug Shortages Delay Cancer Clinical Trials

Jnci.oxfordjournals.org: June 15, 2012. The mean survival time for people older than 60 years with acute myeloid leukemia (AML) is about 7 months. Only 15% survive 5 years or longer, and that percentage hasn’t changed in decades. The poor prognosis for these patients is due in part to the fact that many cannot tolerate the toxic chemotherapy used as […]

Peaches, Plums, Nectarines Give Obesity, Diabetes Slim Chance

Businesswire.com: June 18, 2012 10:00 AM Eastern Daylight Time COLLEGE STATION, Texas–(BUSINESS WIRE)–Peaches, plums and nectarines have bioactive compounds that can potentially fight-off obesity-related diabetes and cardiovascular disease, according to new studies by Texas AgriLife Research. “bioactive compounds of a fruit have been shown to potentially work in different fronts against a disease.” The study, which will […]

Diabetes and Cause-specific Mortality in a Prospective Cohort of One Million U.S. Adults

Diabetes Care June 14, 2012. OBJECTIVE Diabetes is a major predictor of death from heart disease and stroke; its impact on nonvascular mortality, including specific cancers, is less understood. We examined the association of diabetes with cause-specific mortality, including deaths from specific cancers. RESEARCH DESIGN AND METHODS A prospective cohort of 1,053,831 U.S. adults, without cancer at baseline, […]

Type 2 Diabetes – Ongoing And Continuous Clinical Support Crucial

Medicalnewstoday.com: Article Date: 14 Jun 2012 – 11:00 PDT A new study has found that patients diagnosed with Type 2 diabetes are more likely to benefit in the long term if they receive ongoing and sustained clinical support instead of a one-off session when they are first diagnosed. The study, published in British Medical Journal (BMJ), […]

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2012 National Minority Quality Forum, Inc. All Rights Reserved.